VIDAS? TOXO IGG II 30210

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,foreig report with the FDA on 2016-07-14 for VIDAS? TOXO IGG II 30210 manufactured by Biomerieux Sa.

Event Text Entries

[49568269] A customer in (b)(6) notified biomerieux regarding discrepant results with the vidas toxo igg ii test kit (reference 30210) the customer reports that two samples were previously tested by a laboratory where the pure sample was tested at dilutions of 1/5 and 1/10; these results, per the customer, demonstrated that the performance did not produce an acceptable level of linearity. The customer reports testing previous samples on a new batch of product using a new vidasinstrument; this testing resulted in a confirmation of the previous non-linear results. In this incident, the customer reported the death of a patient related to congenital toxoplasmosis; however, the physician indicated the death was not related to results obtained by the vidasoxo igg ii, but instead related to underlying problems the patient had. An internal biomerieux investigation will be initiated.
Patient Sequence No: 1, Text Type: D, B5


[55006065] This report was initially submitted following notification that a customer in (b)(6) reported discrepant avidity results in association with the vidas toxo igg (txg) ii assay. Biom? Rieux investigation was conducted. The issue can occur when it is necessary to bring the sample titer to 15 ui/ml, as stated in package insert of vidas toxo igg avidity. Evaluation of the manufacturing batch record for the referenced lot indicated no anomaly or nonconformity associated with the batch. Internal testing demonstrated that: there is no issue with the sensitivity nor the specificity of the test. The vidas toxo igg ii is within the expected performance claimed in the package insert. In the vidas toxo igg ii application, some high titer samples may be underestimated when diluted but there is no risk of false negative results. In the vidas toxo igg avidity application, the vidas system will display "invalid results" if the sample dilution is not optimal, but there is no risk of false avidity results. The investigation concluded the performance of vidas txg ii assay is within specifications.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3002769706-2016-00117
MDR Report Key5795347
Report SourceCOMPANY REPRESENTATIVE,FOREIG
Date Received2016-07-14
Date of Report2016-06-27
Date Mfgr Received2016-06-27
Date Added to Maude2016-07-14
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. JONATHAN NONNEMACHER
Manufacturer Street100 RODOLPHE STREET
Manufacturer CityDURHAM NC 27712
Manufacturer CountryUS
Manufacturer Postal27712
Manufacturer Phone9196203396
Manufacturer G1BIOMERIEUX SA
Manufacturer StreetCHEMIN DE L ORME
Manufacturer CityMARCY L ETOILE, RHONE 69280
Manufacturer CountryFR
Manufacturer Postal Code69280
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Sequence Number: 0

Brand NameVIDAS? TOXO IGG II
Generic NameVIDAS? TOXO IGG II
Product CodeGLZ
Date Received2016-07-14
Catalog Number30210
Lot Number1004465080
Device Expiration Date2016-09-08
OperatorHEALTH PROFESSIONAL
Device Availability*
Device Eval'ed by MfgrN
Device Sequence No0
Device Event Key0
ManufacturerBIOMERIEUX SA
Manufacturer AddressCHEMIN DE L ORME MARCY L ETOILE, RHONE 69280 FR 69280

Device Sequence Number: 1

Brand NameVIDAS? TOXO IGG II
Generic NameVIDAS? TOXO IGG II
Product CodeCHP
Date Received2016-07-14
Catalog Number30210
Lot Number1004465080
Device Expiration Date2016-09-08
OperatorHEALTH PROFESSIONAL
Device Availability*
Device AgeDA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerBIOMERIEUX SA
Manufacturer AddressCHEMIN DE L ORME MARCY L ETOILE, RHONE 69280 FR 69280


Patients

Patient NumberTreatmentOutcomeDate
101. Death 2016-07-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.